Bellevue Asset Management (Switzerland)’s Juniper Pharmaceuticals, Inc. Common Stock JNP Stock Holding History

Bellevue Asset Management (Switzerland)’s Portfolio JNP Stock Details JNP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	$515K	Hold	50,000	–	–	0.08%	114
2015 Q3	$589K	Sell	50,000 -60,000	-55%	-$663K	0.1%	118
2015 Q2	$1.01M	Hold	110,000	–	–	0.14%	109
2015 Q1	$682K	Buy	+110,000	New	+$680K	0.1%	126

Other funds holding JNP

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

JAM

JW Asset Management Miami Beach, Florida $320M AUM 140.1% 1-Year Est. Return

KAM

Krensavage Asset Management New York $256M AUM 69.63% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

GCP

GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

EAM Investors Solana Beach, California $866M AUM 377.14% 1-Year Est. Return

BlackRock Advisors Wilmington, Delaware $98.8B AUM 39.77% 1-Year Est. Return

Bellevue Asset Management (Switzerland)'s JNP Position: Q4 2015 in Review

Bellevue Asset Management (Switzerland) held its Juniper Pharmaceuticals, Inc. Common Stock (JNP) position steady in Q4 2015 at 50,000 shares worth $515K. The position accounts for 0.08% of the portfolio, ranked #114.

Bellevue Asset Management (Switzerland) first reported a position in JNP in Q1 2015 and has held it in 4 quarters since. The position peaked at $1.01M in Q2 2015. 54 funds tracked by Wall St. Rank hold JNP as of Q4 2015.

Bellevue Asset Management (Switzerland) held 50,000 shares of Juniper Pharmaceuticals, Inc. Common Stock worth $515K as of Q4 2015.
Bellevue Asset Management (Switzerland) left its Juniper Pharmaceuticals, Inc. Common Stock share count unchanged in Q4 2015.
Juniper Pharmaceuticals, Inc. Common Stock made up 0.08% of Bellevue Asset Management (Switzerland)'s portfolio in Q4 2015, its #114 holding.
Bellevue Asset Management (Switzerland) first reported a position in Juniper Pharmaceuticals, Inc. Common Stock in Q1 2015 and has held it in 4 quarters since.
Bellevue Asset Management (Switzerland)'s Juniper Pharmaceuticals, Inc. Common Stock position peaked at $1.01M in Q2 2015.
54 funds tracked by Wall St. Rank held Juniper Pharmaceuticals, Inc. Common Stock as of Q4 2015.

Based on Bellevue Asset Management (Switzerland)'s 13F filing for Q4 2015, filed 12 Feb 2016.